| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |